150 State St., Albany,
NY, USA, 12207
According to a comprehensive study by KD Market Insights analyzes and forecasts the Radioactive Stents market at both global and regional level. The report provides an analysis of 6 years, in which 2017 is the base year, 2018 as an estimated year and 2019-2023 is forecasted period. The report consists of overall market size in 2017 and its anticipated growth in further 6 years. It gives grasp about the high demanding region for Radioactive Stents. It also includes the factors that drive the growth of the market along with emerging and current opportunities. The competitor's strategies for long-term and short-term goals are also a key part of this research methodology.
The report includes an in-depth price chain analysis, that provides an in depth read of the world Radioactive Stents market. The Porter’s 5 Forces analysis provided within the report helps to know the competitive state of affairs within the international Radioactive Stents market. The study incorporates market attractiveness analysis, whereby the market segments for product type and application square measure benchmarked supported their market size, rate of growth, and attractiveness in terms of chance. so as to grant an entire analysis of the general competitive state of affairs within the Radioactive Stents market, each geographical area mentioned within the report is supplied with attractiveness analysis.
A market Overview chapter explains the market trends and dynamics that embody the market drivers, restraining factors, and opportunities for the present and future Radioactive Stents market. Market outlook analysis has been provided globally within the report. to boot, the report conjointly provides analysis of various business ways being adopted by market leaders of the Radioactive Stents market. Market introduction chapter assists in gaining an inspiration of various trends and services associated with Radioactive Stents.
The research offers a comprehensive analysis of Radioactive Stents market with respect to various sub-markets. The segmentation of Radioactive Stents is by Product Type, by End User, by Stent size and by global regions. By Product Type, the market is sub-segmented into directed Retrograde Stents, Antegrade Stents, Internal (Double-J) Stents, Iodine-125 Radioactive Stents, Others. By End User, the market is sub-segmented into directed Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy, Angiography, Neointimal Hyperplasia, Esophageal Cancer, Biliary Cancer, Others. By Stent Size, the market is sub-segmented into directed 18 mm, 20 mm, 14 mm, Other Stents.
The report covers every segment so that every segment is analyzed properly, and every area is considered while preparing the report so that requirements from that particular area can be analyzed and further modification can be made accordingly. The Geographical areas covered in this report are North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Russia, Spain and rest of Europe), Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa), Latin America (Argentina, Mexico, Brazil and Rest of Latin America). The report covers the leading trends in the market, insights and plan and policies adopted by the competitors in the market that can hamper the conditions of the market.
The report describes the key competitors ruling in the market and plans and strategies adopted by them to grab their target market and working with consistency in the market so that company can prepare itself beforehand for the unforeseen circumstances. The key players profiled in the global Radioactive Stents market includes C.R. Bard, Inc., Cook Medical Inc., Medline Industries Ltd, Pnn Medical A/S, Allium Medical Solutions Ltd., APC Cardiovascular Ltd., Micro-Tech Pvt. Ltd., Changzhou Zhiye Co Ltd., Aetna Inc., Abbott Laboratories, Others Major & Niche Key Players. Companies are focusing on expanding their business through strategic acquisitions and partnerships with several end-use industries.
In the last section of the report, the current scenario of the market has been shown to provide a better overview of the market. The report highlights the data collected by the report. A perfect combination of the primary, as well as secondary research, has been made to collect all the facts and figures about the market and the company itself. Primary data research includes telephonic interviews; e-mail conversation, face to face interviews whereas secondary research includes the annual report depicting the financial position of the company, government regulations, shareholders reviews and statistical database. The further secondary method has been considered as a reliable method as a comparison to primary data.
By Product Type
- Retrograde Stents
- Antegrade Stents
- Internal (Double-J) Stents
- Iodine-125 Radioactive Stents
By End User
- Percutaneous Nephrolithotomy
- Neointimal Hyperplasia
- Esophageal Cancer
- Biliary Cancer
By Stent Size
- 18 mm
- 20 mm
- 14 mm
- Other Stents
- C.R. Bard, Inc.
- Cook Medical Inc.
- Medline Industries Ltd
- Pnn Medical A/S
- Allium Medical Solutions Ltd.
- APC Cardiovascular Ltd.
- Micro-Tech Pvt. Ltd.
- Changzhou Zhiye Co Ltd.
- Aetna Inc.
- Abbott Laboratories
- Others Major & Niche Key Players
Market Definition and List of Abbreviations
1. Executive Summary
2. Growth Drivers & Issues in Global Radioactive Stents Market
3. Global Radioactive Stents Market Trends
4. Opportunities in Global Radioactive Stents Market
5. Recent Industry Activities, 2017
6. Porter's Five Forces Analysis
7. Market Value Chain and Supply Chain Analysis
8. Global Radioactive Stents Market Size (USD Million), Growth Analysis and Forecast, (2017-2023)
9. Global Radioactive Stents Market Segmentation Analysis, By Product Type
9.2. Market Attractiveness, By Product Type
9.3. BPS Analysis, By Product Type
9.4. Retrograde Stents
9.5. Antegrade Stents
9.6. Internal (Double-J) Stents
9.7. Iodine-125 Radioactive Stents
10. Global Radioactive Stents Market Segmentation Analysis, By Stent Size
10.2. Market Attractiveness, By Stent Size
10.3. BPS Analysis, By Stent Size
10.4. 18 mm
10.5. 20 mm
10.6. 14 mm
10.7. Other Stents
11. Global Radioactive Stents Market Segmentation Analysis, By End-User
11.2. Market Attractiveness, By End-User
11.3. BPS Analysis, By End-User
11.7. Percutaneous Nephrolithotomy
11.9. Neointimal Hyperplasia
11.10. Esophageal Cancer
11.11. Biliary Cancer
12. Geographical Analysis
12.2. North America Radioactive Stents Market Size (USD Million) & Volume, 2017-2023
12.2.1. By Product Type
12.2.2. By Stent Size
12.2.3. By End-User
12.2.4. By Country
188.8.131.52. Market Attractiveness, By End-user
184.108.40.206. BPS Analysis, By End-User
220.127.116.11. U.S. Market Size (USD Million) 2017-2023
18.104.22.168. Canada Market Size (USD Million 2017-2023
12.3. Europe Radioactive Stents Market Size (USD Million) & Volume, 2017-2023
12.3.1. By Product Type
12.3.2. By Stent Size
12.3.3. By End-User
12.3.4. By Country
22.214.171.124. Market Attractiveness, By Country
126.96.36.199. BPS Analysis, By Country
188.8.131.52. Germany Market Size (USD Million) 2017-2023
184.108.40.206. United Kingdom Market Size (USD Million) 2017-2023
220.127.116.11. France Market Size (USD Million) 2017-2023
18.104.22.168. Italy Market Size (USD Million) 2017-2023
22.214.171.124. Spain Market Size (USD Million) 2017-2023
126.96.36.199. Russia Market Size (USD Million) 2017-2023
188.8.131.52. Rest of Europe Market Size (USD Million) 2017-2023
12.4. Asia Pacific Radioactive Stents Market Size (USD Million), 2017-2023
12.4.1. By Product Type
12.4.2. By Stent Size
12.4.3. By End-User
12.4.4. By Country
184.108.40.206. Market Attractiveness, By Country
220.127.116.11. BPS Analysis, By Country
18.104.22.168. China Market Size (USD Million) 2017-2023
22.214.171.124. India Market Size (USD Million) 2017-2023
126.96.36.199. Japan Market Size (USD Million) 2017-2023
188.8.131.52. South Korea Market Size (USD Million) 2017-2023
184.108.40.206. Indonesia Market Size (USD Million) 2017-2023
220.127.116.11. Taiwan Market Size (USD Million) 2017-2023
18.104.22.168. Australia Market Size (USD Million) 2017-2023
22.214.171.124. New Zealand Market Size (USD Million, 2017-2023
126.96.36.199. Rest of Asia Pacific Market Size (USD Million) 2017-2023
12.5. Latin America Radioactive Stents Market Size (USD Million) 2017-2023
12.5.1. By Product Type
12.5.2. By Stent Size
12.5.3. By End-User
12.5.4. By Country
188.8.131.52. Market Attractiveness, By Country
184.108.40.206. BPS Analysis, By Country
220.127.116.11. Brazil Market Size (USD Million) 2017-2023
18.104.22.168. Mexico Market Size (USD Million) 2017-2023
22.214.171.124. Rest of Latin America Market Size (USD Million, 2017-2023
12.6. Middle East & Africa Radioactive Stents Market Size (USD Million) 2017-2023
12.6.1. By Product Type
12.6.2. By Stent Size
12.6.3. By End-User
12.6.4. By Geography
126.96.36.199. Market Attractiveness, By Geography
188.8.131.52. BPS Analysis, By Geography
184.108.40.206. GCC Market Size (USD Million) 2017-2023
220.127.116.11. North Africa Market Size (USD Million) 2017-2023
18.104.22.168. South Africa Market Size (USD Million) 2017-2023
22.214.171.124. Rest of Middle East & Africa Market Size (USD Million) 2017-2023
13. Competitive Landscape
13.1. Market Share of Key Players
13.2. Market Positioning of Major Players in Global Radioactive Stents Market
13.3. Company Profiles
13.3.1. C.R. Bard, Inc.
126.96.36.199. Product Offered
188.8.131.52. Business Strategy
184.108.40.206. SWOT Analysis
220.127.116.11. Market Share Analysis
18.104.22.168. Key Achievements & Developments
13.3.2. C.R. Bard, Inc.
13.3.3. Cook Medical Inc.
13.3.4. Medline Industries Ltd
13.3.5. Pnn Medical A/S
13.3.6. Allium Medical Solutions Ltd.
13.3.7. APC Cardiovascular Ltd.
13.3.8. Micro-Tech Pvt. Ltd.
13.3.9. Changzhou Zhiye Co Ltd.
13.3.10. Aetna Inc.
13.3.11. Abbott Laboratories
13.3.12. Other Major & Niche Players